Abstracts Archive - Page 135 of 1683 - ATC Abstracts

2022 American Transplant Congress
Evaluation of Prophylactic Valganciclovir Dosing in Kidney Transplant Recipients at an Urban Transplant Institution
E. Foster¹, D. Pierce¹, T. Cairns¹, S. Borgetti², I. Tzvetanov³, E. Benedetti³, C. Muran¹
¹Pharmacy, University of Illinois at Chicago, Chicago, IL, ²Medicine, University of Illinois at Chicago, Chicago, IL, ³Surgery, University of Illinois at Chicago, Chicago, IL
*Purpose: Dosing and duration of cytomegalovirus (CMV) prophylaxis with valganciclovir (VGC) in kidney transplant (KT) recipients is variable by transplant center. Prior studies have shown…
2022 American Transplant Congress
Exacerbation of Racial Disparities in Living Donor Kidney Transplant During the Covid-19 Pandemic
N. Singh¹, R. Li², T. Alhamad³, M. A. Schnitzler⁴, R. B. Mannon⁵, M. D. Doshi⁶, K. J. Woodside⁶, B. E. Hippen⁷, M. Cooper⁸, J. Snyder⁹, D. A. Axelrod¹⁰, K. L. Lentine⁴
¹Willis Knighton Health System, Shreveport, LA, ²Saint Louis University, Saint Louis, MO, ³Washington University, Saint Louis, MO, ⁴Saint Louis University Center for Abdominal Transplantation, Saint Louis, MO, ⁵University of Nebraska Medical Center, Omaha, NE, ⁶University of Michigan, Ann Arbor, MI, ⁷Metrolina Nephrology, Associates, Charlotte, NC, ⁸Medstar Georgetown Transplant Institute, Washington, DC, ⁹Hennepin Healthcare Research Institute, Minneapolis, MN, ¹⁰University of Iowa, Iowa City, IA
*Purpose:The SARS-CoV-2 or coronavirus disease 2019 (COVID-19) pandemic has disproportionately impacted racial and ethnic minority groups in the United States. Although, kidney transplant procedures decreased…
2022 American Transplant Congress
Correction of Hyperoxaluria in a Primary Hyperoxaluria Type 2 Patient After Simultaneous Liver Kidney Transplantation
K. Genena, D. Milliner, J. Lieske
Nephrology and Hypertension, Mayo Clinic, Rochester, MN
*Purpose: To demonstrate the role of simultaneous liver kidney transplant in PH2*Methods: A 30-year-old white man presented to our center for evaluation of chronic kidney…
2022 American Transplant Congress
Impact Of Nirmatrelvir-Ritonavir On Tacrolimus Concentrations
S. Fredrick¹, B. Wise², L. Bowman², D. DeWolfe¹, J. Taylor¹, J. Melaragno¹
¹University of Rochester Medical Center, Rochester, NY, ²Tampa General Hospital, Tampa, FL
*Purpose: Ritonavir (RTV), a component of the oral antiviral agent nirmatrelvir-RTV (Paxlovid) for COVID-19 infection, increases tacrolimus concentrations through strong competitive inhibition of gastrointestinal and…
2022 American Transplant Congress
Fibrin Deposition in Ischemic Damaged Liver Grafts and Reconditioning with Thrombolytic Therapy During Normothermic Machine Perfusion
T. Goto, Y. Noguchi, S. Ganesh, B. Arulratnam, M. Kawamura, C. Parmentier, S. Ray, T. Reichman, N. Selzner, M. Selzner
Ajmera Transplant Program, Department of Surgery, Toronto General Hospital, University Health Network, Toronto, ON, Canada
*Purpose: Normothermic ex situ perfusion (NMP) is a novel technique for the storage and assessment of marginal livers retrieved from donors after circulatory death (DCD).…
2022 American Transplant Congress
Rates Of Dermatology Follow-up And New Skin Cancer Diagnosis Among Solid Organ Transplant Recipients During The Covid-19 Pandemic
R. Saranath, J. Gomez, B. Fernandez, E. Shah, S. Michalak, I. Ahronowitz
USC Keck School of Medicine, Los Angeles, CA
*Purpose: Solid organ transplant recipients (SOTRs) are at an elevated risk of developing non-melanoma skin cancers. Routine dermatologic surveillance has been shown to improve skin…
2022 American Transplant Congress
Sars-cov-2 Antibodies Transitions After Vaccination In Solid Organ Transplant Recipients: Multicenter Study In Japan
K. Unagami¹, M. Yoshikawa², Y. Natori³, K. Omoto¹, H. Ishida¹, H. Date⁴, R. Imamura⁵, T. Ito⁴, K. Miyaji⁶, S. Takahara⁷, K. Yuzawa⁸, O. Satoko⁹, Y. Hirota¹⁰, H. Egawa¹
¹Tokyo Women's Medical University, Tokyo, Japan, ²Kyoto Prefectural University of Medicine, Kyoto, Japan, ³University of Miami, Pinecrest, FL, ⁴Kyoto University, Kyoto, Japan, ⁵Dept. of Urology, Osaka Univ. Graduate School of Medicine, Suita, Japan, ⁶Renal Transplantation, Takatsuki General Hospital, Takatsuki, Japan, ⁷Kansai Medical Hospital, Toyonaka, Japan, ⁸Tranplantation Surgery, National Hospital Organization Mito Medical Center, Mito, Japan, ⁹Public Health, Osaka City University Graduate School of Medicine and Research Center for Infectious, Osaka City University Graduate School of Medicine, Osaka, Japan, ¹⁰Clinical Epidemiology Research Center, Miyama, Japan
*Purpose: For purpose of SARS-CoV-2 infection control, vaccination was started in worldwide, however, low reactivity of antibody production after vaccination is a concern for solid…
2022 American Transplant Congress
Prediction of Waitlist Mortality in Liver Transplant Candidates: Do Time-Varying Models Help?
A. Kwong¹, W. Kim¹, D. Schladt², A. Wey², J. Snyder², A. Israni², J. Lake³
¹Stanford University, Stanford, CA, ²Hennepin Healthcare Research Institute, Minneapolis, MN, ³University of Minnesota, Minneapolis, MN
*Purpose: In the United States, priority on the liver transplant waitlist is determined by the model for end-stage liver disease (MELD)-Na, a score composed of…
2022 American Transplant Congress
Disparities in Low Respiratory Vaccination Among Solid Organ Transplant Recipients
J. R. Felzer¹, A. M. LeMahieu², L. J. Finney Rutten², Y. Juhn³, C. Wi³, R. M. Jacobson³, C. C. Kennedy¹
¹Medicine, Mayo Clinic, Rochester, MN, ²Quantitative Health Sciences, Mayo Clinic, Rochester, MN, ³Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN
*Purpose: There are many potential infections post-transplant, with influenza as the most common vaccine-preventable infection the first 5 years post-transplant. Despite effective vaccines, uptake is…
2022 American Transplant Congress
Obinutuzumab in Kidney Transplantation: Effect on B-cell Counts and Crossmatch Tests
M. M. Nasrallah¹, M. Elalfy¹, Y. Elmesseery², I. Amer¹, P. Malvezzi³, L. Rostaing⁴
¹Misr International Hospital, Cairo, Egypt, ²Misr International Hospital, Caire, Egypt, ³CHU Grenoble-Alpes, Grenoble, France, ⁴Service de Néphrologie, CHU Grenoble-Alpes, Grenoble, France
*Purpose: Resistance to the action of rituximab (RTX), has been documented in several diseases. More recently, obinutuzumab (OBZ) has shown promise where RTX has failed…